Search Login Register

AB Variant Tay-Sachs Disease Summary

Description: A progressive neurodegenerative disorder that begins with muscle weakness, then progresses to startle reaction, retardation and seizures. It is characterized by the accumulation of G(M2) GANGLIOSIDE in neurons that is caused by a lack of G(M2) ACTIVATOR PROTEIN function. The AB variant designation refers to the increase of both HEXOSAMINIDASE A and HEXOSAMINIDASE B in tissues that lack of G(M2) activator protein.

Also Known As: Tay-Sachs Disease, AB Variant; AB Variant Gangliosidosis GM2; Deficiency Disease, GM2 Protein Activator; GM2 Activator Deficiency Disease; Hexosaminidase Activator Protein Deficiency Disease; Tay Sachs Disease, AB Variant; GM2 Protein Activator Deficiency Disease; Gangliosidosis GM2, AB Variant; Gangliosidosis GM2, Type AB

Networked: 1 relevant articles (0 outcomes, 0 trials/studies) for this Disease

Key Drugs and Agents for AB Variant Tay-Sachs Disease

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. G(M2) Ganglioside (Ganglioside GM2) : 1 result : IBA

Diseases Related to AB Variant Tay-Sachs Disease

  1. GM2 Gangliosidoses (GM2 Gangliosidosis)
  2. Sandhoff Disease (Sandhoff's Disease)

Key Therapies for AB Variant Tay-Sachs Disease

Efficacy Chart >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.